News in Brief
Pharmacology - Oct 23
Novartis announces European Medicines Agency (EMA) has granted orphan drug designation for iptacopan (LNP023) in IgA nephropathy (IgAN)
Novartis announces European Medicines Agency (EMA) has granted orphan drug designation for iptacopan (LNP023) in IgA nephropathy (IgAN)
news
« BACK
Innovation - Research Management - 14.02.2018 
Research influences innovation on a global scale
How much impact does research carried out at individual universities have on innovation globally? To find out, a team of scientists from several schools developed a ranking system based on citations in patent literature. And on that score, EPFL sits in seventh place, just behind Stanford and above the California Institute of Technology.
Research Management
Result 1 - 1 of 1.
How much impact does research carried out at individual universities have on innovation globally? To find out, a team of scientists from several schools developed a ranking system based on citations in patent literature. And on that score, EPFL sits in seventh place, just behind Stanford and above the California Institute of Technology.
News in Brief
Pharmacology - Oct 23
Novartis announces European Medicines Agency (EMA) has granted orphan drug designation for iptacopan (LNP023) in IgA nephropathy (IgAN)
Novartis announces European Medicines Agency (EMA) has granted orphan drug designation for iptacopan (LNP023) in IgA nephropathy (IgAN)